<DOC>
	<DOCNO>NCT01860092</DOCNO>
	<brief_summary>This post-approval study implement monitor use Argus II System large US population available within pre-approval study . An attempt make include eligible willing subject implant Argus II System United States . Safety data monitor ensure continued acceptability risk study subject . The utility ( i.e . visual function functional vision ) reliability Argus II System also evaluate . There study hypothesis .</brief_summary>
	<brief_title>New Enrollment Post-Approval Study ArgusÂ® II Retinal Prosthesis System</brief_title>
	<detailed_description />
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<criteria>Are adult , age 25 year older ; Have severe profound retinitis pigmentosa ; Bare light light perception eye ; patient residual light perception , evidence intact inner layer retina function must confirm ; Have previous history useful form vision . Aphakic pseudophakic . ( If patient phakic prior implant , natural lens remove implant procedure . ) Patients willing able receive recommend postimplant clinical followup , device fitting , visual rehabilitation ; Have consent implantation Argus II Retinal Prosthesis subsequently consent participate study ; At time Baseline Visit , suffer nonophthalmic serious adverse event ( e.g . myocardial infarction , etc . ) Ocular disease condition could prevent Argus II System work ( e.g . optic nerve disease , central retinal artery vein occlusion , history retinal detachment , trauma , severe strabismus ) ; Ocular structure condition could prevent successful implantation Argus II Implant adequate healing surgery ( e.g . extremely thin conjunctiva , axial length &lt; 20.5 mm &gt; 26 mm , corneal ulcer , etc . ) ; Ocular disease condition ( cataract ) prevent adequate visualization inner structure eye ( e.g . corneal opacity , etc . ) ; Inability tolerate general anesthesia recommend antibiotic steroid regimen associate implantation surgery ; Metallic active implantable device ( ) ( e.g . cochlear implant ) head ; Predisposition eye rub ; Any disease condition prevents understand communication inform consent , study demand , test protocol , include : cognitive decline include diagnosed form dementia and/or progressive neurologic disease , psychiatric disease include diagnose form depression ; speak principal language associate region , deafness ; Pregnant wish become pregnant course study ; Participating another investigational drug device study may conflict objective , followup test study ; Conditions likely limit life less 1 year time inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>